《大行報告》美銀美林下調上石化(00338.HK)目標價至3元評級「跑輸大市」
美銀美林發表研究報告,預期上石化(00338.HK)今年第二季除稅前溢利8億元人民幣,按年減少54%,主要是因為更好的息稅前利潤表現被較弱的化學品價差抵銷。另外,料上半年的淨利潤為14億元人民幣,意味按年下跌60%。
該行相信,公司或會在石化市場失卻市佔率。另外,基於疲弱的化學品毛利率前景,將其2019至2021年純利預測下調15%至23%,重申其「跑輸大市」投資評級,目標價由原來的3.5元下調至3元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.